For the study, 564 U.S. Special Operations Forces personnel (mean age 43 years, 563 men) were evaluated in the Comprehensive Brain Health and Trauma Program. In a large sample of United States (U.S.) ...
GCC Medical Consumables Market is projected to grow at a steady CAGR of around 4.73% during 2026–2032. According to the latest study published by MarkNtel Advisors, the GCC Medical Consumables Market ...
Pharmacovigilance has traditionally required organizations to balance the urgency of reporting with the rigor of accurately detecting adverse event and product complaints. AI has the potential to ease ...
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease BD (Becton, Dickinson and Company) (NYSE: BDX), a ...
In her role with Metacarpal, Richer will focus on clinical education and support, helping prosthetists, therapists, and care teams understand where the Metacarpal GEM can fit within care pathways and ...
Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership. Stealth BioTherapeutics (the “Company” or “Stealth”), a commercial-stage biotechnology company ...
Post-traumatic headaches are one of the most common symptoms following a car accident and one of the most legally complicated to pursue in a personal injury claim. They are common in the general ...
In a world where convenience often wins out over quality, fresh, organic vegetables offer a refreshing return to food that nourishes both the body and the planet. They’re more than a trend; they ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company ...
Dealing with both mental health issues and substance use disorders in tandem can feel overwhelming. Many individuals find that symptoms from one disorder often aggravate the other, complicating not ...
Inaugural case performed by spine surgeon Dr. Scott L. Parker highlights the system's strength, versatility, and precision for supporting multi-level spinal constructs Genesys Spine today announced ...
Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, today announced FDA approval to initiate the SUPPORT II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results